Fractyl Health to Present at BofA Securities 2024 Health Care Conference
May 08 2024 - 5:00AM
Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic
therapeutics company focused on pioneering new approaches for the
treatment of obesity and type 2 diabetes (T2D), today announced
that Dr. Harith Rajagopalan, CEO of Fractyl Health, will
participate in a fireside chat at the upcoming BofA Securities 2024
Health Care Conference on Wednesday, May 15, 2024, at 4:20 p.m. PDT
(7:20 p.m. EDT).
To register in advance for the fireside chat webcast, sign up
here.
A webcast replay will be accessible following the live session
on the Events page of the Investors section on the Company’s
website at https://ir.fractyl.com/.
About Fractyl Health
Fractyl Health is a metabolic therapeutics company focused on
pioneering new approaches to the treatment of metabolic diseases,
including obesity and T2D. Despite advances in treatment over the
last 50 years, obesity and T2D continue to be rapidly growing
drivers of morbidity and mortality in the 21st century. Fractyl
Health’s goal is to transform metabolic disease treatment from
chronic symptomatic management to durable disease-modifying
therapies that target the organ-level root causes of disease.
Fractyl Health is based in Burlington, MA. For more information,
visit www.fractyl.com or https://twitter.com/FractylHealth.
Contacts
Corporate Contact Lisa Davidson, Chief Financial
Officer ir@fractyl.com, 781.902.8800
Media Contact Beth Brett, Corporate
Communications bbrett@fractyl.com,
720.656.6544
Investor ContactStephen Jasper Gilmartin
Groupstephen@gilmartinir.com, 619.949.3681
Fractyl Health (NASDAQ:GUTS)
Historical Stock Chart
From May 2024 to Jun 2024
Fractyl Health (NASDAQ:GUTS)
Historical Stock Chart
From Jun 2023 to Jun 2024